Comparison of primary angioplasty with conservative therapy in patients with acute myocardial infarction and contraindications for thrombolytic therapy

Catheterization and Cardiovascular Interventions

Volumn 46, Issue 2, 1999, Pages 127-133

  Zahn, Ralf ^a   Schuster, Stefan ^b   Schiele, Rudolf ^a   Seidl, Karlheinz ^a   Voigtländer, Thomas ^c   Meyer, Jürgen ^c   Hauptmann, Karl E ^d   Gottwik, Martin ^e   Berg, Gunther ^f   Kunz, Thomas ^g   Gieseler, Ulf ^g   Jakob, Michael ^h   Senges, Jochen ^a  

^a KLINIKUM LUDWIGSHAFEN   (Germany)

^b St Antonius Hosp   (Germany)

^c JOHANNES GUTENBERG UNIVERSITY   (Germany)

^d KRANKENHAUS DER BARMHERZIGEN BRÜDER   (Germany)

^e KLINIKUM NÜRNBERG   (Germany)

^f SAARLAND UNIVERSITY   (Germany)

^g Winterbergkliniken ^*  (Germany)

^h Knappschafts Krankenhaus   (Germany)

Author keywords

Contraindication; Myocardial infarction; Primary angioplasty; Thrombolysis

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ANGIOPLASTY; ARTICLE; BLOOD CLOT LYSIS; CONSERVATIVE TREATMENT; FIBRINOLYTIC THERAPY; HEART FAILURE; HEART INFARCTION; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MORTALITY; PREVALENCE; PROSPECTIVE STUDY; ST SEGMENT; STATISTICAL ANALYSIS; TREATMENT CONTRAINDICATION; TREATMENT INDICATION;

EID: 0032924439     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/(sici)1522-726x(199902)46:2<127::aid-ccd2>3.0.co;2-g     Document Type: Article

References (36)

1. Ryan TJ, Anderson JL, Antman EM, Braniff BA, Brooks NH, Califf RM, Hillis LD, Hiratzka LF, Rapaport E, Riegel BJ, Russell RO, Smith EE III, Weaver WD. ACC/AHA guidelines for the management of patients with acute myocardial infarction: Executive summary. Circulation 1996;94:2341-2350.
2. International Society and Federation of Cardiology and World Health Organization Task Force on Myocardial Reperfusion. Reperfusion in acute myocardial infarction. Circulation 1994;90: 2091-2102.
3. Anderson HV, Willerson JT. Thrombolysis in acute myocardial infarction. N Eng J Med 1993;329:703-709.
4. de Boer MJ, Hoorntje JCA, Ottervanger JP, Reiffers S, Suryapranata H, Ziljlstra F. Immediate coronary angioplasty vs. intravenous streptokinase in acute myocardial infarction: Left ventricular ejection fraction, hospital mortality and reinfarction. J Am Coll Cardiol 1994;23:1004-1008.
5. Every NR, Parsons LS, Hlatky M, Martin JS, Weaver WD. A comparison of thrombolytic therapy with primary coronary angioplasty for acute myocardial infarction. N Engl J Med 1996;335: 1253-1260.
6. Gibbons RJ, Holmes DR, Reeder GS, Bailey KR, Hopfenspirger MR, Gersh BJ, for the Mayo Coronary Care Unit and Catheterization Laboratory Group. Immediate angioplasty compared with the administration of a thrombolytic agent followed by conservative treatment for myocardial infarction. N Engl J Med 1993;328:685-691.
7. Grines CL, Browne KF, Marco J, Pothbaum D, Stone GW, O'Keefe J, Overlie P, Donohue B, Chelliah N, Timmis GC, Vlietstra RE, Strzelecki M, Puchrowicz-Ochocki S, O'Neill WW, for the Primary Angioplasty in Myocardial Infarction Study Group. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. N Engl J Med 1993;328: 673-679.
8. Michels KB, Yusuf S. Does PTCA in acute myocardial infarction affect mortality and reinfarction rates? a quantitative overview (meta-analysis) of the randomized trials. Circulation 1995;91:476-485.
9. O'Keefe JO, Bailey WL, Rutherford BD, Hartzler GO. Primary angioplasty for acute myocardial infarction in 1000 consecutive patients. Am J Cardiol 1993;72:107G-115G.
10. O'Neill W, Brodie BR, Ivanhoe R. Knopf W. Taylor G, O'Keefe JO, Grines CL, Weintraub R, Sickinger BG, Berdan LG, Tcheng JE, Woodlief LH, Strzelecki M, Kanzler G, Califf RM. Primary coronary angioplasty for acute myocardial infarction (the primary angioplasty registry). Am J Cardiol 1994;73:627-634.
11. O'Neill W, Timmis GC, Bourdillon PD, Lai P, Ganghadarhan V, Walton J Jr, Ramos R, Laufer N, Gordon S, Schork MA. A prospective randomized trial of intracoronary streptokinase vs. coronary angioplasty for acute myocardial infarction. N Engl J Med 1986;314:812-818.
12. Ribeiro, EE, Silva LA, Cameiro R, D'Oliveira LG, Gasquez A, Amino JG, Tavares JR, Petrizzio A, Torossian S, Duprat R, Buffolo E, Ellis SG. Randomized trial of direct coronary angioplasty vs. intravenous streptokinase in acute myocardial infarction. J Am Coll Cardiol 1993;22:376-380.
13. The Gobal Use of Strategies to Open Occluded Arteries in Acute Coronary Syndromes (GUSTO IIb) Angioplasty Substudy Investigators. A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction. N Engl J Med 1997;336:1621-1628.
14. Zahn R, Koch A, Rustige J, Schiele R, Wirtzfeld A, Neuhaus K, Kuhn H, Gülker H, Senges J, for the ALKK Study Group. Primary angioplasty vs. thrombolysis in the treatment of acute myocardial infarction - a matched pairs study. Am J Cardiol 1997;79:264-269.
15. Zijlstra F, de Boer MJ, Hoorntje JCA, Reiffers S, Reiber JHC, Suryapranata H. A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction. N Engl J Med 1993;328:680-684.
16. Hochman, JS, Boland J, Sleeper LA, Porway M, Brinker J, Col J, Jacobs A, Slater J, Miller D, Wasserman H, Menegus MA, Talley D, McKimlay S, Sanborn T, LeJemtel T, the SHOCK Registry Investigators. Current spectrum of cardiogenic shock and effect of early revascularization on mortality: Results of an international registry. Circulation 1995;91:873-881.
17. Moosvi AR, Khaja F, Villanueva L, Gheorghiade M, Douthat L, Goldstein S. Early revascularization improves survival in cardiogenic shock complicating acute myocardial infarction. J Am Coll Cardiol 1992;19:907-914.
18. Brodie BR, Weintraub RA, Stuckey TD, LeBauer EJ, Katz JD, Kelly TA, Hansen CJ. Outcomes of direct coronary angioplasty for acute myocardial infarction in candidates and non-candidates for thrombolytic therapy. Am J Cardiol, 1991;67:7-12.
19. Stone GW, Grines CL, Browne KF, Marco J, Rothbaum D, O'Keefe JH, Hartzler GO, Overlie P, Donohue B, Chelliah N, Vlietstra R, Puchromicz-Ochocki S, O'Neill WW, for the Primary Angioplasty in Myocardial Infarction (PAMI) Investigators. Outcome of different reperfusion strategies in patients with former contraindications to thrombolytic therapy: A comparison of primary angioplasty and tissue plasminogen activator. Cath Cardiovasc Diagn 1996;39:333-339.
20. Waldecker, B, Waas W, Heizmann H, Haberbosch W, Voss R, Walker G, Schäfer M, Kistler P, Tillmanns H. PTCA for acute myocardial infarction in patients not eligible for iv thrombolysis: In-hospital results. Fibrinolysis 1995;9(suppl 1):126-128.
21. Schuster S, Koch A, Burczyk U, Schiele R, Wagner S, Zahn R, Glunz HG, Heinrich F, Stuby K. Berg G, Voigtländer T, Gieseler U, Jakob M, Hauptmann P, Senges J, für die MITRA Studien-Gruppe. Frühbehandlung des akuten Myokardinfarkts: Umsetzung von Therapierichtlinien in den klinischen Alltag, MITRA Pilotphase. Z Kardiol 1997;86:273-283.
22. Brodie BR. Primary angioplasty in a community hospital in the USA: Insights into the advantages and limitations. Br Heart J 1995;73:411-412.
23. Boyle RM. Immediate angioplasty in the United Kingdom. Br Heart J 1995;73:413-414.
24. Juliard J, Himbert D, Golmard J, Aubry P, Karrillon GJ, Boccara A, Benamer H, Steg G. Can we provide reperfusion therapy to all unselected patients admitted with acute myocardial infarction? J Am Coll Cardiol 1997;30:157-164.
25. Caputo RP, Ho KKL, Stoler RC, Sukin CA, Lopez JJ, Cohen DJ, Kuntz RE, Herman A, Carrozza JP, Baim DS. Effect of continues quality improvement analysis on the delivery of primary percutaneous transluminal angioplasty for acute myocardial infarction. Am J Cardiol 1997;79:1159-1164.
26. Jollis JG, DeLong ER, Peterson ED, Muhlbaier LH, Fortin DF, Califf RM, Mark DB. Outcome of acute myocardial infarction according to the specialty of the admitting physician. N Engl J Med 1996;335:1880-1887.
27. Antiplatelet Trialist' Collaboration. Collaborative overview of randomized trails of antiplatelet therapy-I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Br Med J 1994;308:81-106.
28. Gruppo Italiano per lo Studio della Sopravivenca nell'Infarto Miocardico. GISSI-3: Effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6 week mortality and ventricular function after acute myocardial infarction. Lancet 1994;343:1115-1122.
29. Hjalmarson A, Herlitz J, Holmberg S, Ryden L, Swedberg K, Vedin A, Waagstein F, Waldenstrom A, Waldenstrom J, Wedel H, Wilhelmsen L, Wilhelmsson C. The Goteborg metoprolol trial: Effects on mortality and morbidity in acute myocardial infarction. Circulation 1983;67:126-132.
30. ISIS-1 (First International Study of Infarct Survival) Collaborative Group. Randomized trial of intravenous atenolol among 16027 cases of acute myocardial infarction: ISIS-1. Lancet 1986;2: 57-66.
31. ISIS-4 Collaborative Group. ISIS-4: A randomized factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58050 patients with suspected acute myocardial infarction. Lancet 1995;345:669-685.
32. Latini, R, Maggioni AP, Flather M, Sleight P, Tognoni G, for the meeting participants. ACE inhibitors use in patients with myocardial infarction: Summary of evidence from clinical trials. Circulation 1995;92:3132-3137.
33. Pfeffer MA, Braunwald E, Moyé LA, Basta L, Brown EJ, Cuddy TE, Davis BR, Geltman EM, Goldman S, Flaker GC, Klein M, Lamas GA, Packer M, Rouleau J, Rouleau JL, Rutherford J, Wertheimer JH, Hawkins CM, for the SAVE investigators. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: Results of the Survival and Ventricular Enlargement Trial (SAVE). N Eng J Med 1992;327:669-677.
34. Althouse R, Maynard C, Cerquera MD, Olsufka M, Ritchie JL, Kennedy JW. The Western Washington myocardial infarction registry and emergency department tissue plasminogen activator treatment trial. Am J Cardiol 1990;66:1298-1303.
35. Cragg DR, Friedman HZ, Bonema JD, Jaiyesimi IA, Ramos RG, Timmis GC, O'Neill WW, Schreiber TL. Outcome in patients with acute myocardial infarction who are ineligible for thrombolytic therapy. Ann Intern Med 1991;115:173-175.
36. Himbert D, Juliard J, Steg G, Badaoui G, Baleynaud S, Le Guludec D, Aumont M, Gourgon R. Primary angioplasty for acute myocardial infarction with contraindication to thrombolysis. Am J Cardiol 1993;71:377-381.